Risk Factors for Penile Cancer
Demographic and Anatomical Risk Factors
- The median age of penile cancer diagnosis in the United States is 68 years, with increased risk in men older than 50 years 1, 2
- Penile cancer is rare in Western countries (0.4-0.6% of male malignancies) but has higher incidence (up to 10%) in developing countries of Asia, Africa, and South America 2
- The most common sites of occurrence are the glans (34.5%), inner preputial layer, coronal sulcus, and prepuce (13.2%), with shaft involvement in 5.3% of cases 1
Major Modifiable Risk Factors
- Phimosis is associated with 25-60% increased risk of penile cancer and significantly hinders early detection by preventing proper examination of high-risk areas 1
- HPV infection is associated with 45-80% of penile cancers, with strong correlation to types 16 and 18 1, 2
- Tobacco use is associated with a 3.0-4.5 times increased risk of developing penile cancer 1, 2
Inflammatory and Dermatologic Risk Factors
- Lichen sclerosus is associated with a 2-9% risk of developing penile carcinoma 1, 3
- Chronic inflammation and balanitis are significant risk factors for penile cancer development 1
- PUVA therapy is associated with a 286 times higher risk of penile cancer than the general population 1
Other Risk Factors
- HIV infection is associated with an 8-fold increased risk of penile cancer, possibly related to higher HPV co-infection rates 1, 2
- Poor hygiene contributes to chronic inflammation and infection 1, 3
- History of sexually transmitted diseases is associated with increased risk of penile cancer 1, 2
- Penile trauma can lead to chronic inflammation 1, 2
Clinical Implications and Prevention
- Early detection is crucial as penile cancer has approximately 50% 5-year survival rate overall, with better outcomes for node-negative disease (>85%) 2
- Proper genital hygiene is recommended as a preventive measure 3
- Regular examination is recommended for men with risk factors, especially those with lichen sclerosus 3
- Patients with lichen sclerosus require long-term follow-up due to risk of malignant transformation 3